Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 23 of 1,261
  1. US 12377104

    Methods for treating a fatty liver disease

    Madrigal Pharmaceuticals, Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  2. US 12379385

    Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function

    Maximus Diagnostic Technologies LLC · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  3. US 12378558

    RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  4. US 12378553

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  5. US 12377082

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  6. US 12378231

    Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof

    APOGEE PHARMACEUTICALS, INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  7. US 12378560

    Sequence multiplicity within spherical nucleic acids

    Northwestern University · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  8. US 12377112

    Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

    Compass Pathfinder Limited · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  9. US 12377186

    Antimicrobial biopolymer compositions, methods of synthesis, and applications of use

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  10. US 12377093

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  11. US 12378540

    Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof

    DENALI THERAPEUTICS INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  12. US 12377036

    Melanin hair dye with thickeners

    Northwestern University · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  13. US 12378288

    Multimeric bicyclic peptide ligands

    BicycleTx Limited · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  14. US 12377051

    Microspheres for extended, controlled release of therapeutic agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  15. US 12378280

    Deoxynucleic guanidines (DNG)-modified oligonucleotides and methods of synthesizing deoxynucleic guanidine strands

    Northwestern University · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  16. US 12378286

    Methods and compositions useful for inhibiting growth of certain bacteria

    The Regents of the University of California · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  17. US 12377078

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  18. US 12378201

    Histone demethylase inhibitors for treating cancers

    The Board of Regents of the University of Texas System · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  19. US 12377069

    Compounds, compositions, methods of using, and methods for preparing compounds

    THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM) · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  20. US 12377191

    Chondroinductive peptides and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  21. US 12378256

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  22. US 12378277

    SGLTS/DPP4 inhibitor and application thereof

    DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  23. US 12377135

    GHRH antagonists for use in a method of treating sarcoidosis

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  24. US 12377159

    Steroids and protein-conjugates thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.